Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical characteristics of a large cohort of patients with narcolepsy candidate for pitolisant: a cross-sectional study from the Italian PASS Wakix® Cohort.
Mutti C, Brunetti V, Figorilli M, Liguori C, Pizza F, Proserpio P, Sacco T, Pedrazzi G, Lecomte I, Blanchard N, Agostoni EC, Bonanni E, Centonze D, Cicolin A, Della Marca G, Ferini-Strambi L, Ferri R, Gigli GL, Izzi F, Liguori R, Lodi R, Nobili L, Parrino L, Placidi F, Puligheddu M, Romigi A, Savarese MA, Terzaghi M, Plazzi G. Mutti C, et al. Among authors: lecomte i. Neurol Sci. 2022 Sep;43(9):5563-5574. doi: 10.1007/s10072-022-06210-9. Epub 2022 Jun 25. Neurol Sci. 2022. PMID: 35750949 Free PMC article.
Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial.
Szakacs Z, Dauvilliers Y, Mikhaylov V, Poverennova I, Krylov S, Jankovic S, Sonka K, Lehert P, Lecomte I, Lecomte JM, Schwartz JC; HARMONY-CTP study group. Szakacs Z, et al. Among authors: lecomte i. Lancet Neurol. 2017 Mar;16(3):200-207. doi: 10.1016/S1474-4422(16)30333-7. Epub 2017 Jan 25. Lancet Neurol. 2017. PMID: 28129985 Clinical Trial.
Pitolisant for Daytime Sleepiness in Patients with Obstructive Sleep Apnea Who Refuse Continuous Positive Airway Pressure Treatment. A Randomized Trial.
Dauvilliers Y, Verbraecken J, Partinen M, Hedner J, Saaresranta T, Georgiev O, Tiholov R, Lecomte I, Tamisier R, Lévy P, Scart-Gres C, Lecomte JM, Schwartz JC, Pépin JL; HAROSA II Study Group collaborators. Dauvilliers Y, et al. Among authors: lecomte i. Am J Respir Crit Care Med. 2020 May 1;201(9):1135-1145. doi: 10.1164/rccm.201907-1284OC. Am J Respir Crit Care Med. 2020. PMID: 31917607 Free PMC article. Clinical Trial.
Pitolisant for Residual Excessive Daytime Sleepiness in OSA Patients Adhering to CPAP: A Randomized Trial.
Pépin JL, Georgiev O, Tiholov R, Attali V, Verbraecken J, Buyse B, Partinen M, Fietze I, Belev G, Dokic D, Tamisier R, Lévy P, Lecomte I, Lecomte JM, Schwartz JC, Dauvilliers Y; HAROSA I Study Group. Pépin JL, et al. Among authors: lecomte i. Chest. 2021 Apr;159(4):1598-1609. doi: 10.1016/j.chest.2020.09.281. Epub 2020 Oct 26. Chest. 2021. PMID: 33121980 Clinical Trial.
Long-term outcome and treatment modifications in a prospective cohort of human immunodeficiency virus type 1-infected patients on triple-drug antiretroviral regimens. Triest Cohort Investigators.
Girard PM, Guiguet M, Bollens D, Goderel I, Meyohas MC, Lecomte I, Raguin G, Frottier J, Rozenbaum W, Jaillon P. Girard PM, et al. Among authors: lecomte i. Clin Infect Dis. 2000 Oct;31(4):987-94. doi: 10.1086/318154. Epub 2000 Oct 25. Clin Infect Dis. 2000. PMID: 11049781
24 results